EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

CRISPR-driven strategies to disrupt methicillin-resistant Staphylococcus aureus biofilms: a review

Jose Jurel M Nuevo, Jamil Allen G Fortaleza, Kevin Smith P Cabuhat, Christian Joseph N Ong, Anna C Jalova, Ferdinand A Mortel, Grace D Bacalzo

Frontiers in Cellular and Infection Microbiology · 2026

DOI: 10.3389/fcimb.2026.1784529 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2026. Verfasst von Jose Jurel M Nuevo und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Medical Laboratory Science, Our Lady of Fatima University, Valenzuela City, Philippines. Hauptthemen laut MEDLINE: Biofilms, Methicillin-Resistant Staphylococcus aureus, CRISPR-Cas Systems. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 186 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Methicillin-resistant Staphylococcus aureus exhibits heightened tolerance to antimicrobial therapy through restricted drug penetration, extracellular polymeric substance-mediated protection, metabolic heterogeneity, and persister cell formation, limiting the effectiveness of current treatment strategies. CRISPR-Cas systems have emerged as programmable antimicrobial tools capable of targeting resistance genes, virulence determinants, and regulatory pathways; however, existing approaches remain largely gene-centric and insufficiently integrated with the biological complexity of biofilm-associated infections. This review aims to provide a comprehensive and integrative analysis of CRISPR-based strategies for targeting MRSA biofilms by linking molecular CRISPR mechanisms with key biofilm processes and evaluating their translational potential. CRISPR-Cas systems have emerged as programmable antimicrobial platforms with the ability to selectively target resistance genes, virulence factors, and regulatory networks. In MRSA biofilms, these systems are increasingly being explored for their potential to disrupt biofilm-associated determinants and weaken the molecular basis of persistence. Recent advances involving Cas9, Cas12a, and Cas13 highlight the potential of CRISPR-based targeting to interfere with resistance mechanisms, quorum sensing pathways, and structural components relevant to biofilm stability. Emerging in vivo studies, particularly those using engineered bacteriophages and localized delivery systems, provide early evidence that CRISPR-based strategies can reduce bacterial burden and impair biofilm integrity under physiologically relevant conditions. Nevertheless, significant barriers remain, including limited penetration into mature biofilms, delivery inefficiency, off-target activity, immunogenicity, resistance evolution, and regulatory uncertainty. Ultimately, CRISPR-based interventions represent a promising but still developing approach for the control of MRSA biofilm-associated infections, requiring further refinement in delivery design, target selection, and translational validation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiofilmsMethicillin-Resistant Staphylococcus aureusCRISPR-Cas SystemsHumansQuorum SensingAnti-Bacterial AgentsStaphylococcal InfectionsVirulence Factors

Stichwörter der Autor:innen

antibiotic resistanceantimicrobialsefflux pumpquorum sensingβ-lactam

Substanzen

Anti-Bacterial AgentsVirulence Factors

Autor:innen und Institutionen

  • College of Medical Laboratory Science, Our Lady of Fatima University, Valenzuela City, Philippines.
  • National University Philippines, Manila, Philippines.
  • Department of Biology, College of Science, De La Salle University, Manila, Philippines.
  • Basic Education Department, La Consolacion University Philippines, Malolos, Bulacan, Philippines.
  • College of Medical Technology, Manila Central University, Caloocan City, Philippines.
  • College of Medical Technology, Centro Escolar University, Malolos, Philippines.

Zitieren

APA

Nuevo, J. J. M., Fortaleza, J. A. G., Cabuhat, K. S. P., Ong, C. J. N., Jalova, A. C., Mortel, F. A., & Bacalzo, G. D. (2026). CRISPR-driven strategies to disrupt methicillin-resistant Staphylococcus aureus biofilms: a review. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2026.1784529

Vancouver

Nuevo JJM, Fortaleza JAG, Cabuhat KSP, Ong CJN, Jalova AC, Mortel FA, et al. CRISPR-driven strategies to disrupt methicillin-resistant Staphylococcus aureus biofilms: a review. Frontiers in Cellular and Infection Microbiology. 2026. doi:10.3389/fcimb.2026.1784529

BibTeX
@article{Nuevo2026,
  author = {Nuevo, Jose Jurel M and Fortaleza, Jamil Allen G and Cabuhat, Kevin Smith P and Ong, Christian Joseph N and Jalova, Anna C and Mortel, Ferdinand A and Bacalzo, Grace D},
  title = {CRISPR-driven strategies to disrupt methicillin-resistant Staphylococcus aureus biofilms: a review},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2026},
  doi = {10.3389/fcimb.2026.1784529}
}
Kostenlos starten →